Abstract
Empirical antibiotic therapy is the preferred primary treatment modality for chronic bacterial prostatitis (CBP). However, this method of treatment has a low success rate and long-term therapy may result in complications and the appearance of resistant strains. Therefore a new alternative method for the prevention of CBP is necessary. There are several reports that ginsenoid has a preventive effect on urinary tract infection (UTI). To evaluate the preventive effect of ginsenoid on CBP compared to conventional antibiotics, we carried out an experiment in a rat model of the disease. Four groups of adult male Wistar rats were treated with the following medications: (1) control (no medication), (2) ciprofloxacin, (3) ginsenoid, and (4) ciprofloxacin/ginsenoid. All medications were given for 4 weeks, and then we created a CBP model in the animals by injecting an Escherichia coli Z17 (O2:K1;H−) suspension into the prostatic urethra. After 4 weeks, results of microbiological cultures of prostate and urine samples, as well as histological findings of the prostate in each group were analyzed. The microbiological cultures of the prostate samples demonstrated reduced bacterial growth in all experimental groups compared with the control group. Histopathological examination showed a significantly decreased rate of infiltration of inflammatory cells into prostatic tissue and decreased interstitial fibrosis in the ginsenoid group compared with the control group. Inhibition of prostate infection was greater in the group receiving both ginsenoid and antibiotic than in the single-medication groups. Although the findings of this study suggest a preventive effect of ginsenoid, preventive methods for CBP are still controversial.
Similar content being viewed by others
References
Pfau A. Prostatitis. A continuing enigma. Urol Clin North Am. 1986;13:695–715.
Nickel JC, Olson ME, Costerton JW. Rat model of experimental bacterial prostatitis. Infection. 1991;19(Suppl 3):S126–30.
Stamey TA, Meares EM Jr, Winningham DG. Chronic bacterial prostatitis and diffusion of drugs into prostatic fluid. J Urol. 1970;103:187–94.
Nickel JC. Antibiotics for bacterial prostatitis. J Urol. 2000;163:1407.
Song ZJ, Johansen HK, Faber V, Hoiby N. Ginseng treatment enhances bacterial clearance and decreases lung pathology in athymic rats with chronic P. aeruginosa pneumonia. APMIS. 1997;105:438–44.
Ahn JY, Song JY, Yun YS, Jeong G, Choi IS. Protection of Staphylococcus aureus-infected septic mice by suppression of early acute inflammation and enhanced antimicrobial activity by ginsan. FEMS Immunol Med Microbiol. 2006;46:187–97.
Park EK, Choo MK, Han MJ, Kim DH. Ginsenoside Rh1 possesses antiallergic and anti-inflammatory activities. Int Arch Allergy Immunol. 2004;133:113–20.
Matsuda H, Samukawa K, Kubo M. Anti-inflammatory activity of ginsenoside ro 1. Planta Med. 1990;56:19–23.
Yu SC, Li XY. Effect of ginsenoside on IL-1 beta and IL-6 mRNA expression in hippocampal neurons in chronic inflammation model of aged rats. Acta Pharmacol Sin. 2000;21:915–8.
Seo SI, Lee S, Kim JC, Choi Y, Sw SW, Hwang TK, Cho Y. Effects of androgen deprivation on chronic bacterial prostatitis in a rat model. Int J Urol. 2003;10:485–91.
Han CH, Yang CH, Sohn DW, Kim SW, Kang SH, Cho YH. Synergistic effect between lycopene and ciprofloxacin on a chronic bacterial prostatitis rat model. Int J Antimicrob Agents. 2008;31(S1):S102–7.
Lee YS, Han CH, Kang SH, Lee S, Kim SW, Shin OR, Sim Y, Cho Y. Synergistic effect between catechin and ciprofloxacin on chronic bacterial prostatitis rat model. Int J Urol. 2005;12:383–9.
Sohn DW, Han CH, Jung YS, Kim SI, Kim SW, Cho Y. Anti-inflammatory and antimicrobial effects of garlic and synergistic effect between garlic and ciprofloxacin in a chronic bacterial prostatitis rat model. Int J Antimicrob Agents. 2009;34:215–9.
Jantos C, Altmannsberger M, Weidner W, Schiefer HG. Acute and chronic bacterial prostatitis due to E. coli. Description of an animal model. Urol Res. 1990;18:207–11.
Moon TD. Questionnaire survey of urologist and primary care physicians’ diagnostic and treatment practices for prostatitis. Urology. 1997;50:543–7.
Terai A, Yamamoto S, Mitsumori K, Okada Y, Kurazono H, Takeda Y, et al. Escherichia coli virulence factors and serotypes in acute bacterial prostatitis. Int J Urol. 1997;4:289–94.
Neal DE Jr, Moon TD. Use of terazosin in prostatodynia and validation of a symptom score questionnaire. Urology. 1994;43:460–5.
Nicolle LE. Uncomplicated urinary tract infection in adults including uncomplicated pyelonephritis. Urol Clin North Am. 2008;35:1–12.
Wagenlehner FM, Weidner W, Naber KG. An update on uncomplicated urinary tract infections in women. Curr Opin Urol. 2009;19:368–74.
Xie X, Eberding A, Madera C, Fazli L, Jia W, Goldenberg L, et al. Rh2 synergistically enhances paclitaxel or mitoxantrone in prostate cancer models. J Urol. 2006;175:1926–31.
Kim HS, Lee EH, Ko SR, Choi KJ, Park JH, Im DS. Effects of ginsenosides Rg3 and Rh2 on the proliferation of prostate cancer cells. Arch Pharm Res. 2004;27:429–35.
Song Z, Johansen HK, Faber V, Moser C, Kharazmi A, Rygaard J, et al. Ginseng treatment reduces bacterial load and lung pathology in chronic Pseudomonas aeruginosa pneumonia in rats. Antimicrob Agents Chemother. 1997;41(5):961–4.
Yang G, Bao T, Fu N, Geng P. Preliminary study of the modulating effects of ginseng on immunity in vivo and in vitro. Acta Bethune Med Univ. 1983;9:1–4 (in Chinese).
Yang G, Bao T, Yu Y. Immune modulating effects of ginseng in vivo and in vitro. Commun Med Res. 1987;16:220–1 (in Chinese).
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Kim, S.H., Ha, US., Sohn, D.W. et al. Preventive effect of ginsenoid on chronic bacterial prostatitis. J Infect Chemother 18, 709–714 (2012). https://doi.org/10.1007/s10156-012-0406-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10156-012-0406-7